The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials.
about
The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The use of cerebrospinal fluid ...... mer's disease clinical trials.
@en
type
label
The use of cerebrospinal fluid ...... mer's disease clinical trials.
@en
prefLabel
The use of cerebrospinal fluid ...... mer's disease clinical trials.
@en
P2860
P921
P1476
The use of cerebrospinal fluid ...... mer's disease clinical trials.
@en
P2093
Bob Olsson
Jonathan M Schott
P2860
P304
P356
10.1080/14737175.2017.1341311
P577
2017-06-12T00:00:00Z